Literature DB >> 17356554

Probiotic capsules do not lower plasma lipids in young women and men.

K A Greany1, M J L Bonorden, J M Hamilton-Reeves, M H McMullen, K E Wangen, W R Phipps, J Feirtag, W Thomas, M S Kurzer.   

Abstract

OBJECTIVE: To investigate the effect of probiotic capsules on plasma lipids.
DESIGN: A randomized, single-blinded, placebo-controlled, parallel-arm trial.
SUBJECTS: Fifty-five normocholesterolemic subjects ages 18-36 (33 premenopausal women and 22 men). INTERVENTION: Each subject consumed either three probiotic capsules each containing a total of 10(9) colony-forming units Lactobacillus acidophilus and Bifidobacterium longum and 10-15 mg fructo-oligosaccharide or three placebo capsules daily for 2 months (men) or two menstrual cycles (women). Plasma lipids were measured before and following the intervention (during the early follicular phase for women).
RESULTS: Plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglyceride were not altered by consumption of probiotic or placebo capsules and were not different between treatment groups following the intervention.
CONCLUSIONS: These results do not support a beneficial effect of Lactobacillus acidophilus strain DDS-1 and Bifidobacterium longum strain UABL-14 on plasma lipids in normocholesterolemic young women and men. SPONSORSHIP: Supported by the Minnesota Agricultural Experiment Station and UAS Laboratories.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356554     DOI: 10.1038/sj.ejcn.1602719

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  13 in total

Review 1.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

2.  Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function in Mild Hypercholesterolemic Volunteers: A Placebo-control, Randomized Clinical Trial.

Authors:  Hui-Fang Chiu; Chia-Yuan Fang; You-Cheng Shen; Kamesh Venkatakrishnan; Chin-Kun Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-01-06       Impact factor: 4.609

3.  Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus.

Authors:  Camila Moroti; Loyanne Francine Souza Magri; Marcela de Rezende Costa; Daniela C U Cavallini; Katia Sivieri
Journal:  Lipids Health Dis       Date:  2012-02-22       Impact factor: 3.876

Review 4.  Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals.

Authors:  Mikiko Shimizu; Masayuki Hashiguchi; Tsuyoshi Shiga; Hiro-omi Tamura; Mayumi Mochizuki
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

5.  Effects of Bifidobacterium animalis subsp. lactis BB-12® on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial.

Authors:  Yujin Lee; Zhaoyong Ba; Robert F Roberts; Connie J Rogers; Jennifer A Fleming; Huicui Meng; Emily J Furumoto; Penny M Kris-Etherton
Journal:  Nutr J       Date:  2017-06-29       Impact factor: 3.271

6.  Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: A randomized placebo-controlled clinical trial.

Authors:  Elnaz Vaghef-Mehrabany; Leila Vaghef-Mehrabany; Mohammad Asghari-Jafarabadi; Aziz Homayouni-Rad; Karim Issazadeh; Beitullah Alipour
Journal:  Health Promot Perspect       Date:  2017-03-05

7.  Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.

Authors:  Rostyslav Bubnov; Lidiia Babenko; Liudmyla Lazarenko; Maryna Kryvtsova; Oleksandr Shcherbakov; Nadiya Zholobak; Olga Golubnitschaja; Mykola Spivak
Journal:  EPMA J       Date:  2019-10-29       Impact factor: 6.543

8.  Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice.

Authors:  Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Viktoria V Mokrozub; Oleksandr A Demchenko; Oleksiy V Nechypurenko; Mykola Ya Spivak
Journal:  EPMA J       Date:  2017-10-10       Impact factor: 6.543

9.  Probiotics, prebiotics, and synbiotics: gut and beyond.

Authors:  Usha Vyas; Natarajan Ranganathan
Journal:  Gastroenterol Res Pract       Date:  2012-09-19       Impact factor: 2.260

10.  A potential synbiotic product improves the lipid profile of diabetic rats.

Authors:  Mariana N Roselino; Nadiége D Pauly-Silveira; Daniela C U Cavallini; Larissa S Celiberto; Roseli A Pinto; Regina C Vendramini; Elizeu A Rossi
Journal:  Lipids Health Dis       Date:  2012-09-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.